NGL Fine-Chem Ltd. said Dhananjay Mungale resigned as nonexecutive independent director Feb. 23.
The Mumbai, India-based company manufactures drugs for animal health and human health applications.
NGL Fine-Chem board member resigns
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
NGL Fine-Chem Ltd. said Dhananjay Mungale resigned as nonexecutive independent director Feb. 23.
The Mumbai, India-based company manufactures drugs for animal health and human health applications.